URO-BCG-4 : Bladder Tumors Immunotherapy Evaluation of maintenance BCG immunotherapy (dose 27 mg) in superficial bladder tumors. Two randomized arms (every 3 or 6 months) will be studied for a population of 300 patients.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

PROSTACOX : Metastatic Prostate Chemotherapy Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.

• Pays France
• Organes Aucun
• Spécialités Aucune